RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Gregory J. Quirk to Adrenergic alpha-Antagonists

Back to Details
This is a "connection" page, showing publications Gregory J. Quirk has written about Adrenergic alpha-Antagonists.
Gregory J. Quirk
Connection Strength
0.932
Adrenergic alpha-Antagonists
  1. Holmes A, Quirk GJ. Pharmacological facilitation of fear extinction and the search for adjunct treatments for anxiety disorders--the case of yohimbine. Trends Pharmacol Sci. 2010 Jan; 31(1):2-7.
    View in: PubMed
    Score: 0.357
  2. Mueller D, Olivera-Figueroa LA, Pine DS, Quirk GJ. The effects of yohimbine and amphetamine on fear expression and extinction in rats. Psychopharmacology (Berl). 2009 Jul; 204(4):599-606.
    View in: PubMed
    Score: 0.337
  3. Quirk GJ. Learning not to fear, faster. Learn Mem. 2004 Mar-Apr; 11(2):125-6.
    View in: PubMed
    Score: 0.238
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support